New insights into atypical Alzheimer's disease in the era of biomarkers. (2021)
Attributed to:
Seeing what they see: compensating for cortical visual dysfunction in Alzheimer's disease
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(20)30440-3
PubMed Identifier: 33609479
Publication URI: http://europepmc.org/abstract/MED/33609479
Type: Journal Article/Review
Volume: 20
Parent Publication: The Lancet. Neurology
Issue: 3
ISSN: 1474-4422